Project documents | Mepolizumab for reducing eosinophilic exacerbations of chronic obstructive pulmonary disease ID1237 | Guidance | NICE

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 1237

Draft matrix post referral (PDF 101 KB)

Published:

02 May 2025
Draft scope post referral (PDF 103 KB)

Published:

02 May 2025

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 308 KB)

Published:

27 September 2017
Draft matrix pre referral (PDF 257 KB)

Published:

27 September 2017